Search research articles
Contact Us
Filters
Showing results (411-420 of 473) with videos related to
Page
of 48
Sort By:
Anti-Cancer Drugs
|
September 27, 2006
Peripheral neuropathy exacerbation associated with topical 5-fluorouracil
Muhammad Wasif Saif, Shahrukh Hashmi, Lori Mattison, et al.
Clinical Lung Cancer
|
April 14, 2009
Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management
Sotirios Tsimboukis, Irene Merikas, Eleni M Karapanagiotou, et al.
Therapeutic Advances in Gastroenterology
|
January 16, 2016
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient
Muhammad Wasif Saif, Komal Wasif, Harriette Butler-Bowen, et al.
Therapeutic Advances in Gastroenterology
|
May 24, 2021
The role of PARP inhibitors in <i>BRCA</i> mutated pancreatic cancer
Jeffrey Chi, Su Yun Chung, Ruwan Parakrama, et al.
JOP : Journal of the Pancreas
|
March 11, 2008
Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer
Susan Alsamarai, Chris Zergebel, Joshua Zhang, et al.
International Journal of Molecular Sciences
|
July 12, 2025
TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients
Muhammad Wasif Saif, Wen-Han Chang, Scott Myers, et al.
Cancer Chemotherapy and Pharmacology
|
May 7, 2011
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors
Muhammad Wasif Saif, John Sarantopoulos, Amita Patnaik, et al.
JOP : Journal of the Pancreas
|
November 13, 2007
Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
Muhammad Wasif Saif, Soonmo Peter Kang, Leslie Ledbetter, et al.
JOP : Journal of the Pancreas
|
September 11, 2013
A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy
Muhammad Wasif Saif, Kristin Kaley, Marianne Brennan, et al.
Anticancer Research
|
September 21, 2012
Gemcitabine-induced pulmonary toxicity
Dow-Chung Chi, Frances Brogan, Ithamar Turenne, et al.
Page
of 48
Search research articles
Search
Showing results (411-420 of 473) with videos related to
Sort By:
Page
of 48
Anti-Cancer Drugs
|
September 27, 2006
Peripheral neuropathy exacerbation associated with topical 5-fluorouracil
Muhammad Wasif Saif, Shahrukh Hashmi, Lori Mattison, et al.
Clinical Lung Cancer
|
April 14, 2009
Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management
Sotirios Tsimboukis, Irene Merikas, Eleni M Karapanagiotou, et al.
Therapeutic Advances in Gastroenterology
|
January 16, 2016
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient
Muhammad Wasif Saif, Komal Wasif, Harriette Butler-Bowen, et al.
Therapeutic Advances in Gastroenterology
|
May 24, 2021
The role of PARP inhibitors in <i>BRCA</i> mutated pancreatic cancer
Jeffrey Chi, Su Yun Chung, Ruwan Parakrama, et al.
JOP : Journal of the Pancreas
|
March 11, 2008
Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer
Susan Alsamarai, Chris Zergebel, Joshua Zhang, et al.
International Journal of Molecular Sciences
|
July 12, 2025
TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients
Muhammad Wasif Saif, Wen-Han Chang, Scott Myers, et al.
Cancer Chemotherapy and Pharmacology
|
May 7, 2011
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors
Muhammad Wasif Saif, John Sarantopoulos, Amita Patnaik, et al.
JOP : Journal of the Pancreas
|
November 13, 2007
Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
Muhammad Wasif Saif, Soonmo Peter Kang, Leslie Ledbetter, et al.
JOP : Journal of the Pancreas
|
September 11, 2013
A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy
Muhammad Wasif Saif, Kristin Kaley, Marianne Brennan, et al.
Anticancer Research
|
September 21, 2012
Gemcitabine-induced pulmonary toxicity
Dow-Chung Chi, Frances Brogan, Ithamar Turenne, et al.
Page
of 48